![Wen Jiang: Benjamin Schrank getting the Society for Immunotherapy of Cancer Merck cancer immunotherapy fellowship](https://oncodaily.com/pub/uploads/2024/08/Screenshot-2024-08-21-10275111-e1724221909746.png)
Wen Jiang: Benjamin Schrank getting the Society for Immunotherapy of Cancer Merck cancer immunotherapy fellowship
Wen Jiang shared on X:
“Super proud of Benjamin Schrank on getting the Society for Immunotherapy of Cancer Merck cancer immunotherapy fellowship to study our novel immune targeted adc for breast cancer.”
Read further.
Source: Wen Jiang/X
Wen Jiang is an Associate Professor with tenure in the Department of Radiation Oncology and a Physician-Scientist in the CNS section at the MD Anderson Cancer Centre. He earned his MD from StanfordUniversity and PhD from University of Toronto. His research focuses on the understanding of immune suppressive mechanisms within solid tumors and identifying novel therapeutic strategies to overcome immune escape.
Benjamin Schrank is a resident physician at the MD Anderson Cancer Center. Previously, he was a resident physician at the Memorial Sloan Kettering Cancer Center. He earned his MD/PhD from the Columbia University Vagelos College of Physicians and Surgeons.He previously served as a Research Technician at the Massachusetts General Hospital.